How Eric Chen built Injective into a billion-dollar blockchain at 22

Executive overview

Most financial products are locked behind capital requirements, brokers, and geography. Injective is a blockchain built specifically for finance — not a general-purpose smart contract platform — designed to give anyone, anywhere, access to the same opportunities as wealthy investors.

Eric Chen co-founded Injective while still in college, survived crypto winter by staying lean, and grew the network to $50B+ in exchange volume. The thesis: build for the long term, ignore present conditions, and let critical users shape the product.

Finance is a game for the rich — blockchain infrastructure can change that.

Surviving the crypto winter

• Early investors disappeared as Bitcoin fell below $6,000 and altcoins collapsed further
• Reduced to a 70–80 sq ft New York apartment shared with three roommates
• Cut costs to extend runway; targeted surviving for more than five years regardless of conditions
• Each user and each dollar had to be earned; incubation capital was managed with extreme discipline
• Lesson learned: capital can disappear for extended periods — treat that as the baseline assumption

Contrarian capital mindset

• Going through the 2019 downturn early created a permanent instinct for caution during bull markets
• Became progressively more fearful during euphoric periods; more optimistic during fearful ones
• Always maintained enough runway to survive — regardless of current conditions
• After multiple cycles, recognising irrational optimism becomes close to a primal instinct

Getting the first 100 users

• Manually joined every crypto group chat relevant to the product
• Personally messaged vocal and active participants — asked them to try the exchange and give honest feedback
• Highly critical users proved to be the most valuable: they care, give precise feedback, and are more constructive than they appear
• Addressed every concern with a positive attitude; iterated the product directly around user feedback
• A single satisfied, vocal user compounds into an outsized growth lever

Why Injective is built differently

• General smart contract platforms (Ethereum, Solana) optimise to handle any application
• Injective is anchored specifically to financial use cases — not a general-purpose computer
• Original research focus: front-running, exchange collusion, and sandwich attacks that extract money from ordinary traders
• Solution used cryptographic techniques to eliminate these attacks at the protocol level

The vision: democratising financial access

• Buying one share of Apple currently requires hundreds of dollars; fractionalisation barely exists in traditional markets
• Injective enables access to real-world assets — stocks, tokenised assets — alongside crypto primitives, from anywhere in the world
• Target: $1–$5 gives the same opportunity set as $5M–$10M in traditional finance
• The impact is subtle but cumulative: slightly more savings, slightly better opportunities, compounding across billions of people

On earned success and long-term thinking

• Asymmetry between output and perceived success is a constant source of doubt
• Staying critical of whether success has been truly earned acts as a long-term anchor
• The original idea came from a borrowed coworking space — a quiet, clear moment before the noise of big visions
• Cherish the rare feeling of genuine clarity; it becomes harder to find as scale and complexity grow